148 related articles for article (PubMed ID: 9054963)
1. Differential toxicity of camptothecin, topotecan and 9-aminocamptothecin to human, canine, and murine myeloid progenitors (CFU-GM) in vitro.
Erickson-Miller CL; May RD; Tomaszewski J; Osborn B; Murphy MJ; Page JG; Parchment RE
Cancer Chemother Pharmacol; 1997; 39(5):467-72. PubMed ID: 9054963
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment of human myelotoxicity of anticancer drugs: a predictive model and the in vitro colony forming unit granulocyte/macrophage (CFU-GM) assay.
Masubuchi N
Pharmazie; 2006 Feb; 61(2):135-9. PubMed ID: 16526561
[TBL] [Abstract][Full Text] [Related]
3. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
McCrady CW; Li F; Pettit GR; Grant S
Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
[TBL] [Abstract][Full Text] [Related]
4. A predictive model of human myelotoxicity using five camptothecin derivatives and the in vitro colony-forming unit granulocyte/macrophage assay.
Masubuchi N; May RD; Atsumi R
Clin Cancer Res; 2004 Oct; 10(19):6722-31. PubMed ID: 15475463
[TBL] [Abstract][Full Text] [Related]
5. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
Lemoli RM; Gulati SC
Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
[TBL] [Abstract][Full Text] [Related]
6. Basic fibroblast growth factor (B-FGF) induces early- (CFU-s) and late-stage hematopoietic progenitor cell colony formation (CFU-gm, CFU-meg, and BFU-e) by synergizing with GM-CSF, Meg-CSF, and erythropoietin, and is a radioprotective agent in vitro.
Gallicchio VS; Hughes NK; Hulette BC; DellaPuca R; Noblitt L
Int J Cell Cloning; 1991 May; 9(3):220-32. PubMed ID: 2061622
[TBL] [Abstract][Full Text] [Related]
7. The opposing actions in vivo on murine myelopoiesis of purified preparations of lactoferrin and the colony stimulating factors.
Broxmeyer HE; Williams DE; Hangoc G; Cooper S; Gentile P; Shen RN; Ralph P; Gillis S; Bicknell DC
Blood Cells; 1987; 13(1-2):31-48. PubMed ID: 3499193
[TBL] [Abstract][Full Text] [Related]
8. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
[TBL] [Abstract][Full Text] [Related]
9. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
10. Culture and characterization of hematopoietic progenitor cells from miniature swine.
Emery DW; Sachs DH; LeGuern C
Exp Hematol; 1996 Jul; 24(8):927-35. PubMed ID: 8690052
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of erythropoietin and GM-CSF on megakaryocytopoiesis from primitive bone marrow cells in serum-free conditions.
Cardier JE; Erickson-Miller CL; Murphy MJ
Stem Cells; 1997; 15(4):286-90. PubMed ID: 9253112
[TBL] [Abstract][Full Text] [Related]
13. Prevention of hematopoietic myeloid and megakaryocyte toxicity associated with zidovudine in vivo in mice with recombinant GM-CSF.
Gallicchio VS; Hughes NK; Tse KF
Growth Regul; 1994 Jun; 4(2):41-7. PubMed ID: 7950902
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo myelotoxicity of CAI to human and murine hematopoietic progenitor cells.
Volpe DA; Cole K; Sandeen MA; Kohn EC
Am J Hematol; 1995 Dec; 50(4):277-82. PubMed ID: 7485102
[TBL] [Abstract][Full Text] [Related]
16. Effect of recombinant human interleukin 3, granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor on human BFU-e in serum-free cultures.
Misago M; Chiba S; Kikuchi M; Tsukada J; Sato T; Oda S; Eto S
Int J Cell Cloning; 1989 Jan; 7(1):39-49. PubMed ID: 2465360
[TBL] [Abstract][Full Text] [Related]
17. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M
Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165
[TBL] [Abstract][Full Text] [Related]
18. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
19. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
Reid CD; Stackpoole A; Meager A; Tikerpae J
J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
[TBL] [Abstract][Full Text] [Related]
20. Canine stem cell factor (c-kit ligand) supports the survival of hematopoietic progenitors in long-term canine marrow culture.
Shull RM; Suggs SV; Langley KE; Okino KH; Jacobsen FW; Martin FH
Exp Hematol; 1992 Oct; 20(9):1118-24. PubMed ID: 1281786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]